Litcius/Paper detail

Impact of Aspirin on clinical outcome in advanced HCC patients receiving sorafenib and regorafenib

Andrea Casadei‐Gardini, Giulia Rovesti, Vincenzo Dadduzio, Caterina Vivaldi, Eleonora Lai, Sara Lonardi, Lorenzo Fornaro, Andrea Pretta, Vittorina Zagonel, Laura Bernardini, Giorgio Astara, F. D‘Amico, Gianluca Masi, Margherita Rimini, Mario Scartozzi, Stefano Cascinu

2020HPB20 citationsDOI

Topics & Concepts

SorafenibMedicineAspirinRegorafenibConcomitantInternal medicineHepatocellular carcinomaRetrospective cohort studyGastroenterologyClinical significanceOncologySurgeryColorectal cancerCancerHepatocellular Carcinoma Treatment and PrognosisCancer Mechanisms and TherapyInflammatory mediators and NSAID effects
Impact of Aspirin on clinical outcome in advanced HCC patients receiving sorafenib and regorafenib | Litcius